MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis
Clinical trial NCT07616401 · RECRUITING
Trial details
- NCT number
- NCT07616401
- Sponsor
- Istituto Auxologico Italiano
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-31
- Primary completion
- 2029-08-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.